Wagh Pushkaraj Rajendra, Desai Preshita, Prabhu Sunil, Wang Jeffrey
Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA, United States.
Front Pharmacol. 2021 Jun 11;12:673209. doi: 10.3389/fphar.2021.673209. eCollection 2021.
Celastrol (also called tripterine) is a quinone methide triterpene isolated from the root extract of (thunder god vine in traditional Chinese medicine). Over the past two decades, celastrol has gained wide attention as a potent anti-inflammatory, anti-autoimmune, anti-cancer, anti-oxidant, and neuroprotective agent. However, its clinical translation is very challenging due to its lower aqueous solubility, poor oral bioavailability, and high organ toxicity. To deal with these issues, various formulation strategies have been investigated to augment the overall celastrol efficacy by attempting to increase the bioavailability and/or reduce the toxicity. Among these, nanotechnology-based celastrol formulations are most widely explored by pharmaceutical scientists worldwide. Based on the survey of literature over the past 15 years, this mini-review is aimed at summarizing a multitude of celastrol nanoformulations that have been developed and tested for various therapeutic applications. In addition, the review highlights the unmet need in the clinical translation of celastrol nanoformulations and the path forward.
雷公藤红素(又称雷公藤甲素)是一种从雷公藤(中药中的雷公藤)根提取物中分离出的苯醌甲基三萜。在过去二十年中,雷公藤红素作为一种强效的抗炎、抗自身免疫、抗癌、抗氧化和神经保护剂受到了广泛关注。然而,由于其水溶性较低、口服生物利用度差和器官毒性高,其临床转化极具挑战性。为了解决这些问题,人们研究了各种制剂策略,试图通过提高生物利用度和/或降低毒性来增强雷公藤红素的整体疗效。其中,基于纳米技术的雷公藤红素制剂受到了全球制药科学家的广泛探索。基于对过去15年文献的调查,本综述旨在总结已开发并针对各种治疗应用进行测试的多种雷公藤红素纳米制剂。此外,该综述还强调了雷公藤红素纳米制剂临床转化中尚未满足的需求以及未来的发展方向。